Cellectar BioSciences Inc. buy Oppenheimer Holdings Inc.
Start price
28.03.24
/
50%
€3.72
Target price
28.03.25
€11.09
Performance (%)
-23.66%
Price
26.04.24
€2.84
Summary
This prediction is currently active. The price of Cellectar BioSciences Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.66%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cellectar BioSciences Inc. | -1.389% | - |
iShares Core DAX® | 2.594% | - |
iShares Nasdaq 100 | 3.553% | - |
iShares Nikkei 225® | 0.687% | - |
iShares S&P 500 | 2.209% | - |
Comments by Oppenheimer_Holdings for this prediction
In the thread Cellectar BioSciences Inc. diskutieren
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $12.00 price target on the stock, up previously from $11.00.
Ratings data for CLRB provided by MarketBeat